Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
21.52
-1.24 (-5.45%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $678.43 million as of July 31, 2026. Its market cap has increased by 200.81% in one year.
Market Cap
678.43M
Enterprise Value
653.30M
1-Year Change
200.81%
Ranking
Category
Stock Price
$21.52
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $678.43M, an increase of 1,069.59%. That is a compound annual growth rate of 72.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 678.43M | 250.80% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 731.95M |
| Candel Therapeutics | 712.92M |
| Pharming Group | 712.11M |
| Climb Bio | 707.74M |
| CytomX Therapeutics | 698.83M |
| Rigel Pharmaceuticals | 697.16M |
| Bright Minds Biosciences | 693.64M |
| Allogene Therapeutics | 676.50M |